[Recording of cell-mediated immunity in patients with gliomatous brain tumors].
The cell-mediated immunity state by detecting lymphokine in the macrophage electrophoresis mobility test (MEM-test) was supervised in 9 patients with gliomatous cerebral tumors and 12 normal subjects. A positive lymphokine proof was provable by application of 100 micrograms antigen in 8 of 9 patients of the tumor group, however, in the control group in 1 of 12 probands. The MEM-test is a practical improvement of the immunodiagnosis especially for tumors of the nervous system despite the high technical and temporal expense.